| 000 | 01449 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517163955.0 | ||
| 264 | 0 | _c20190409 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a1365-2133 | ||
| 024 | 7 |
_a10.1111/bjd.15830 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPeleva, E | |
| 245 | 0 | 0 |
_aRisk of cancer in patients with psoriasis on biological therapies: a systematic review. _h[electronic resource] |
| 260 |
_bThe British journal of dermatology _c01 2018 |
||
| 300 |
_a103-113 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Systematic Review | ||
| 650 | 0 | 4 |
_aAdalimumab _xadverse effects |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBiological Products _xadverse effects |
| 650 | 0 | 4 |
_aDermatologic Agents _xadverse effects |
| 650 | 0 | 4 | _aEpidemiologic Methods |
| 650 | 0 | 4 |
_aEtanercept _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfliximab _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xchemically induced |
| 650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aUstekinumab _xadverse effects |
| 700 | 1 | _aExton, L S | |
| 700 | 1 | _aKelley, K | |
| 700 | 1 | _aKleyn, C E | |
| 700 | 1 | _aMason, K J | |
| 700 | 1 | _aSmith, C H | |
| 773 | 0 |
_tThe British journal of dermatology _gvol. 178 _gno. 1 _gp. 103-113 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bjd.15830 _zAvailable from publisher's website |
| 999 |
_c27381838 _d27381838 |
||